Title: Surgical Management of Complex Hypertrophic Cardiomyopathy Causing Severe Mitral Regurgitation in a Child

Authors: Dr Ajit Kumar Padhy, Dr Sistla Vpl Chandrakumar, Dr Kunwar Sidharth Sourabh, Dr Sankalp Rahi, Dr Ira Balakrishnan, Dr Anubhav Gupta

 DOI: https://dx.doi.org/10.18535/jmscr/v8i3.46

Abstract

   

Mitral leaflet elongation and subvalvular apparatus deformation can be seen in obstructive septal hypertrophy. In such hypertrophic cardiomyopathy (HCM) mitral malformations, the Mitral valve repair   will not suffice to reverse the pathology unless surgical myomectomy is done. Outcome is more gratifying when left ventricular outflow tract obstruction (LVOTO) is eliminated along with abolition of systolic anterior motion (SAM) of mitral leaflet. Trans-esophageal echocardiography (TEE) play a major role in making surgical decision on operating table.

References

  1. Sherrid MV, Shetty A, Winson G, et al. Treatment of obstructive hypertrophic cardiomyopathysymptoms and gradient resistant to first-linetherapy with b-blockade or verapamil. Circ Heart Fail 2013;6:694–702.
  2. Shah PM, Gramiak R, Kramer DH. Ultrasoundlocalization of left ventricular outflow obstructionin hypertrophic obstructive cardiomyopathy. Circulation 1969; 40:3–11..
  3. Cape EG, Simons D, Jimoh A, et al. Chordalgeometry determines the shape and extent of systolic anterior mitral motion: in vitro studies. J Am Colln Cardiol 1989; 13:1438–48.
  4. Joshi S, Patel UK, Yao SS, et al. Standing and exercise Doppler echocardiography in obstructive hypertrophic cardiomyopathy: the range of gradients with upright activity. J Am Soc Echocardiogr 2011; 24:75–82.
  5. Klues HG, Roberts WC, Maron BJ. Anomalousinsertion of papillary muscle directly into anteriormitral leaflet in hypertrophic cardiomyopathy.Significance in producing left ventricular outflow obstruction. Circulation 1991;84: 1188–97.
  6. Maron BJ, Harding AM, Spirito P, et al. Systolicanterior motion of the posterior mitral leaflet: apreviously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophiccardiomyopathy. Circulation 1983;68:282–93.
  7. Grigg LE, Wigle ED, Williams WG, et al. Transesophageal Doppler echocar-diography inobstructive hypertrophic cardiomyopathy: clarificationof pathophysiology and importance inintraoperative decision making. J Am CollCardiol1992;20:42–52.
  8. Schwammenthal E, Nakatani S, He S, et al.Mechanism of mitral regurgitation in hypertrophiccardiomyopathy: mismatch of posterior to anterior leaflet length and mobility. Circulation 1998;98:856–65.
  9. Yu EH, Omran AS, Wigle ED, et al. Mitralregurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol 2000;36:2219–25.
  10. Gersh BJ, Maron BJ, Bonow RO, et al. 2011ACCF/AHA guideline for the diagnosis and treatmentof hypertrophic cardiomyopathy: executive summary: a report of the American College ofCardiology Foundation/American Heart AssociationTask Force on Practice Guidelines. J Am Coll Cardiol 2011; 58:2703–38.
  11. Elliott PM, Anastasakis A, Borger MA, et al.2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J2014;35 :2733–79.
  12. Halpern DG, Swistel DG, Po JR, etal. Echocardiography before and after resect- plicate release surgical myectomy for obstructive hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2015;28:1318–28.
  13. Balaram SK, Ross RE, Sherrid MV, et al. Role ofmitral valve plication in the surgical managementof hypertrophic cardiomyopathy. Ann Thorac Surg 2012; 94:1990–7, discussion 1997–8.
  14. Swistel DG, DeRose JJ Jr., Sherrid MV. Managementof patients with complex hypertrophiccardiomyopathy: resection/ plication/release. OperTech Thorac Cardiovasc Surg 2004;9:261–7.

Corresponding Author

Dr Sistla Vpl Chandrakumar

Senior Resident, Department of CTVS, VMMC & SJH, Delhi